SEC Form 4 · accession 0001481436-16-000009
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald R Blanck
Director
Period of report
May 23, 2016
Accepted (ET)
May 27, 2016 · 10:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | May 23, 2016 | D | 3,500 | $2.62 | A | 20,099 | D |
Table II — derivative securities
No Table II lines on this filing.